BioCryst Pharmaceuticals SG&A Expense (TTM) Trends | YCharts

BioCryst Pharmaceuticals, Inc. (BCRX)

9.96 -0.13 (-1.29%) USD | NASDAQ | Sep 04, 16:00

9.955 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BCRX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.

Date	Value
June 30, 2026	328.11M
March 31, 2026	360.73M
December 31, 2025	348.65M
September 30, 2025	333.34M
June 30, 2025	315.41M
March 31, 2025	289.24M
December 31, 2024	266.13M
September 30, 2024	250.04M
June 30, 2024	235.61M
March 31, 2024	225.39M
December 31, 2023	213.89M
September 30, 2023	199.66M
June 30, 2023	185.94M
March 31, 2023	172.96M
December 31, 2022	159.37M
September 30, 2022	144.60M
June 30, 2022	142.68M
March 31, 2022	130.99M
December 31, 2021	118.82M
September 30, 2021	104.42M
June 30, 2021	86.62M
March 31, 2021	74.18M
December 31, 2020	67.93M
September 30, 2020	57.43M
June 30, 2020	51.97M

Date	Value
March 31, 2020	46.75M
December 31, 2019	37.12M
September 30, 2019	31.12M
June 30, 2019	27.31M
March 31, 2019	28.14M
December 31, 2018	29.51M
September 30, 2018	29.72M
June 30, 2018	25.14M
March 31, 2018	18.48M
December 31, 2017	13.93M
September 30, 2017	11.80M
June 30, 2017	11.21M
March 31, 2017	11.10M
December 31, 2016	11.25M
September 30, 2016	8.692M
June 30, 2016	8.667M
March 31, 2016	9.477M
December 31, 2015	10.33M
September 30, 2015	12.37M
June 30, 2015	11.46M
March 31, 2015	9.934M
December 31, 2014	7.461M
September 30, 2014	6.683M
June 30, 2014	6.208M
March 31, 2014	5.426M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Amgen, Inc.	7.019B
Halozyme Therapeutics, Inc.	238.00M
Vertex Pharmaceuticals, Inc.	2.008B
Agenus, Inc.	38.48M
Anika Therapeutics, Inc.	52.67M